Aging and Cancer Effects (ACE) Study

This study is currently recruiting participants.

Verified by University of Wisconsin, Madison, November 2008

Sponsored by:	University of Wisconsin, Madison
Information provided by:	University of Wisconsin, Madison
ClinicalTrials.gov Identifier:	NCT00204880

Purpose

Hypotheses:

Subjective self-reported data can be used to accurately reflect functioning across the 5 key domains.
Cancer and its various treatment modalities will exert detrimental effects on the 5 key domains in older adults with cancer.
Some aspect of baseline patient characteristic will be predictive of cancer-related outcomes.

Condition
Breast Cancer Lung Cancer

Genetics Home Reference related topics: breast cancer

MedlinePlus related topics: Breast Cancer Cancer Lung Cancer

U.S. FDA Resources

Study Type:	Observational
Study Design:	Case-Only, Prospective
Official Title:	Aging and Cancer: The Effects of Comorbidities on Cancer and it's Treatment

Further study details as provided by University of Wisconsin, Madison:

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	100
Study Start Date:	February 2005

Eligibility

Ages Eligible for Study:	55 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Men and women over the age of 55 newly diagnosed with lung, breast, colon or rectal cancer, and with an anticipated life expectancy of at least 2 years for breast cancer patients,1 year for patients with lung cancer, and 2 years for patients with colon or rectal cancer. There is no upper age limit for participation in this study.

Criteria

Inclusion Criteria:

Willing to do memory testing
Willing to participate in activities of daily living assessment
Can use a cane or walker
Willing to complete a balance performance assessment, if able.

Exclusion Criteria:

Currently receiving treatment for cancer.
Has a previous history of brain cancer
Significant neurological disease other than AD that might affect cognitive function, such as stroke, Parkinson's disease, multiple sclerosis, or serious traumatic brain injury.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00204880

Contacts

Contact: Tamara Markgraf, MBA

1-866-MEMPROG

memory-research@medicine.wisc.edu

Locations

United States, Wisconsin
University of Wisconsin	Recruiting
Madison, Wisconsin, United States, 53792
Contact: Tracy Ohrt, MS 866-636-7764 memory-research@medicine.wisc.edu

Sponsors and Collaborators

University of Wisconsin, Madison

Investigators

Principal Investigator:

Sanjay Asthana, MD

University of Wisconsin, Madison

More Information

Responsible Party:	University of Wisconsin ( Health Sciences Institutional Review Boards )
Study ID Numbers:	2004-0341
Study First Received:	September 13, 2005
Last Updated:	November 8, 2008
ClinicalTrials.gov Identifier:	NCT00204880
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Thoracic Neoplasms
Respiratory Tract Diseases
Skin Diseases
Lung Neoplasms

Lung Diseases
Breast Neoplasms
Breast Diseases

Additional relevant MeSH terms:

Respiratory Tract Neoplasms
Neoplasms
Neoplasms by Site

ClinicalTrials.gov processed this record on January 16, 2009